STAT1 and Huntington disease: We found that JAK1-STAT1/STAT6, p38, and p65 signaling pathways were activated by IL-33 in CD4+ T cells from the PBMCs of HD, whereas annexin A1 silencing partially abolished this response (Figure 4A).